Delta Med Group and Securmed announce a strategic partnership

Delta Med Group and Securmed, among the leaders in the medical device segment, announce a
strategic partnership to create a champion in the Italian and European market.
Delta Med is a leading Italian company specialized in vascular access devices for oncology and
analgesic therapies. White Bridge Investments, the Group’s controlling shareholder, invested in
Delta Med to create a platform in the medical device space.
Securmed is specialised in the production and distribution of medical devices for urology, surgery,
anesthesiology, oxygen therapy and gastroenterology.
This partnership is part of a larger project aiming at creating a European leader in medical
devices for the hospital and home therapy sectors through the aggregation of companies that are
leaders in their niches. In August, Delta Med acquired Adria Med, a leading company in
elastomeric infusion pumps.
Securmed’s main shareholder – the Romagnoli family – will hold a relevant stake in the new
Cristina Georgescu, CEO of Securmed commented, “The partnership with Delta Med represents
a milestone in Securmed’s growth. This transaction will allow us to accelerate our expansion
strategy in Italy and Europe, investing in the best talents and maintaining the high-quality
standards we offer to our clients.“
Gabriele Giovanelli, CEO of Delta Med, added, “Securmed is well-recognized in Italy and abroad
for the development of medical devices for hospitals and home care therapies. The partnership
with Securmed represents another key step in our aggregation project toward the creation of a
European leader focused on medical devices.”
In the transaction, Delta Med was assisted by the law firm White&Case as legal advisor, with
partners Leonardo Graffi and Alessandro Seganfreddo and associates Nicolò Miglio and Ioana
Gaga. Michele Aprile, Paolo Ludovici and Roger Demoro, representing Gatti Pavesi Bianchi
Ludovici, were in charge of the Italian tax aspects, while Michel-Ange of the French tax aspects.
Deloitte was responsible for the financial and tax due diligence, with a team led by Marco
Bastasin for financial aspects and Mario De Blasi for the tax ones. Securmed and its shareholders
were supported by the law firm Gianni & Origoni as legal advisor, with Partner Federico Dettori,
Managing Associate Matteo Canonico and Associate Arianna Paone. The law firm Fidal, with a
team coordinated by Giovanna Figuccio, assisted Securmed and its shareholders for French legal
and tax aspects, while the Partner Gianluca Settepani and Luciano Volta of Studio Gnudi were in
charge of the financial and tax aspects.